Myriad Genetics Inc (MYGN)
18.18
+0.20
(+1.11%)
USD |
NASDAQ |
Apr 26, 16:00
18.18
0.00 (0.00%)
After-Hours: 19:53
Myriad Genetics Cash from Operations (TTM): -110.90M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -110.90M |
September 30, 2023 | -63.50M |
June 30, 2023 | -44.20M |
March 31, 2023 | -93.00M |
December 31, 2022 | -106.30M |
September 30, 2022 | -108.50M |
June 30, 2022 | -145.00M |
March 31, 2022 | -99.70M |
December 31, 2021 | 18.60M |
September 30, 2021 | -31.20M |
June 30, 2021 | 38.10M |
March 31, 2021 | 59.30M |
September 30, 2020 | -14.40M |
June 30, 2020 | 60.70M |
March 31, 2020 | 62.20M |
December 31, 2019 | 52.00M |
September 30, 2019 | 91.70M |
June 30, 2019 | 83.70M |
March 31, 2019 | 100.10M |
December 31, 2018 | 105.00M |
September 30, 2018 | 100.20M |
June 30, 2018 | 115.90M |
March 31, 2018 | 104.60M |
December 31, 2017 | 134.20M |
September 30, 2017 | 132.60M |
Date | Value |
---|---|
June 30, 2017 | 106.20M |
March 31, 2017 | 108.10M |
December 31, 2016 | 112.90M |
September 30, 2016 | 133.60M |
June 30, 2016 | 166.30M |
March 31, 2016 | 178.80M |
December 31, 2015 | 162.80M |
September 30, 2015 | 163.30M |
June 30, 2015 | 140.50M |
March 31, 2015 | 130.42M |
December 31, 2014 | 111.77M |
September 30, 2014 | 106.72M |
June 30, 2014 | 190.20M |
March 31, 2014 | 212.31M |
December 31, 2013 | 238.46M |
September 30, 2013 | 213.03M |
June 30, 2013 | 173.90M |
March 31, 2013 | 152.57M |
December 31, 2012 | 155.92M |
September 30, 2012 | 161.34M |
June 30, 2012 | 141.80M |
March 31, 2012 | 136.47M |
December 31, 2011 | 123.76M |
September 30, 2011 | 133.36M |
June 30, 2011 | 130.83M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-145.00M
Minimum
Jun 2022
91.70M
Maximum
Sep 2019
-19.47M
Average
-22.80M
Median
Cash from Operations (TTM) Benchmarks
Stryker Corp | 3.711B |
Haemonetics Corp | 197.28M |
Perspective Therapeutics Inc | -36.91M |
Electromed Inc | 4.872M |
Xtant Medical Holdings Inc | -9.515M |